Investors

Anteo Diagnostics is an Australian publicly traded company. Our stock trades on the Australian Securities Exchange (ASX) under the ticker symbol ADO
Our proprietary Mix&Go surface coating product has broad applicability in diagnostics and in the life sciences industries. Mix&Go enables a researcher to attach a fragile biomolecule such as a protein to a surface without causing damage. This characteristics makes it possible to develop better diagnostic tests, fast and cheaper.
Anteo Dx licenses its Mix&Go product to companies who incorporate it into their tests. They benefit because their tests show superior performance while reducing cost of goods.
Mix&Go has substantial additional opportunities in areas such as medical devices and drug delivery which Anteo Dx can either pursue itself or license to other companies.

Shareholders requiring information on shareholdings or needing to change contact details can contact Anteo Diagnostics’ share registry:
Registries Limited
ABN 14 003 209 836
Level 7, 207 Kent St
Sydney NSW 2000

Tel 02 9290 9600
Fax 02 9279 0664
Email
Web www.registries.com.au

Information or feedback regarding Investor Relations can be directed to:
shane.hartwig@anteodx.com

Investors

Anteo Diagnostics is an Australian publicly traded company. Our stock trades on the Australian Securities Exchange (ASX) under the ticker symbol ADO

Anteo Dx licenses its Mix&Go product to companies who incorporate it into their tests. They benefit because their tests show superior performance while reducing cost of goods.

Mix&Go has substantial additional opportunities in areas such as medical devices and drug delivery which Anteo Dx can either pursue itself or license to other companies.